Great West Life Assurance Co. Can lowered its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 3.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 137,342 shares of the medical instruments supplier’s stock after selling 5,515 shares during the quarter. Great West Life Assurance Co. Can owned about 0.06% of DENTSPLY SIRONA worth $4,866,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Private Capital Group LLC increased its holdings in shares of DENTSPLY SIRONA by 105.3% in the fourth quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 359 shares during the period. Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. Truehand Inc bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $27,000. Enlightenment Research LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $30,000. Finally, Lindbrook Capital LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $53,000. 99.18% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:XRAY opened at $49.09 on Friday. DENTSPLY SIRONA Inc has a 52-week low of $33.93 and a 52-week high of $57.44. The firm has a market capitalization of $10.92 billion, a P/E ratio of 24.42, a P/E/G ratio of 2.56 and a beta of 1.08. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Friday, March 1st. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.04. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the business earned $0.82 earnings per share. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. Sell-side analysts predict that DENTSPLY SIRONA Inc will post 2.31 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Friday, March 29th will be given a dividend of $0.087 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.35 annualized dividend and a yield of 0.71%. DENTSPLY SIRONA’s payout ratio is 17.41%.
Several research analysts have recently weighed in on XRAY shares. BidaskClub raised shares of DENTSPLY SIRONA from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 12th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $55.00 target price for the company in a research report on Saturday, March 9th. HC Wainwright reiterated a “neutral” rating and issued a $49.00 target price (up from $40.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 4th. Barclays set a $49.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, March 1st. Finally, Robert W. Baird upped their target price on shares of DENTSPLY SIRONA from $42.00 to $50.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $51.33.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Read More: Commodities
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.